Vladimir Petrovich Skulachev

This inventor holds 15 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Mitotech Sa. Active years: 2013-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir Petrovich Skulachev. Retrieved from https://idiyas.com/inventor/vladimir-petrovich-skulachev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 5)

% Patents Active = 66.7

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 15(Granted Patents)

Company Filing History:

15 out of 17

Mitotech Sa

patents

Years Active: 2013-2019

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10188669 - Mitochondria-targeted antioxidants for treatment of age-related brain disorders (2019-01-29),

2. 9744180 - Pharmaceutical formulations containing mitochondrially targeted antioxidants (2017-08-29),

3. 9572890 - Oral formulations of mitochondrially-targeted antioxidants and their preparation and use (2017-02-21),

4. 9572821 - Pharmaceutical compositions for preventing and treating eye pathologies (2017-02-21),

5. 9439916 - Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition (2016-09-13),

6. 9427444 - Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages (2016-08-30),

7. 9408859 - Pharmaceutical compositions useful for preventing and treating cancer (2016-08-09),

8. 9328130 - Method of treating organism by biologically active compounds specifically delivered into mitochondria, pharmaceutical composition required for the use of the method and a compound applicable for this purpose (2016-05-03),

9. 9308214 - Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations (2016-04-12),

10. 9233903 - Pharmaceutical substances on the basis of mitochondria-addressed antioxidants (2016-01-12),

11. 9192676 - Oral formulations of mitochondrially-targeted antioxidants and their preparation and use (2015-11-24),

12. 8658624 - Pharmaceutical compositions for preventing and treating eye pathologies (2014-02-25),

13. 8557733 - Composition for regenerating and stimulating growth of plants and for adapting plants to different stress factors (2013-10-15),

14. 8518915 - Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases (2013-08-27),

15. 8349902 - Pharmaceutical compositions useful for preventing and treating oncological diseases (2013-01-08),

Title: The Legacy of Inventor Vladimir Petrovich Skulachev

Introduction: Vladimir Petrovich Skulachev, a renowned inventor hailing from Moscow, Russia, has made significant contributions to the field of innovation with his groundbreaking work in various scientific disciplines.

Latest Patents: Skulachev's latest patents focus on advancements in bioenergetics and mitochondrial research, showcasing his dedication to pushing the boundaries of scientific knowledge.

Career Highlights: Throughout his illustrious career, Skulachev has been a trailblazer in the field of biophysics, particularly in the study of aging and cell death. His innovative approaches have led to numerous breakthroughs that have revolutionized the way we understand cellular processes.

Collaborations: Skulachev has collaborated with leading scientists and research institutions around the world, fostering a culture of innovation and knowledge-sharing. His collaborative efforts have resulted in multidisciplinary approaches to complex scientific problems.

Conclusion: Vladimir Petrovich Skulachev's pioneering spirit and relentless pursuit of scientific excellence have solidified his legacy as a visionary inventor. His contributions to the field of biophysics continue to inspire future generations of innovators to push the boundaries of what is possible in the realm of scientific discovery.

Profile summary based on public USPTO records.